BioWorld

Nov. 22, 1999

View Archived Issues

Genentech Agrees To Pay $200M To Settle UCSF Patent Dispute

Read More

ImClone, Progenics, Alexion Complete Public Offerings

Read More

In Schizophrenic Brain Activity Test, 'Atypical' Risperidone Scored Over 'Typical' Drugs

Read More

NIH Offers Licenses To Commercialize Technology

Read More

Other News To Note

Read More